Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 11/30/12
Due: 11/30/13
Phase: N/A
Priority: Normal
Start: 09/30/16
End: 07/31/20
Due: 07/31/21
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 12/31/17
Due: 12/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effects of Eltoprazine on Cognitive Impairment Associated With Schizophrenia (CIAS) in Adults | NCT01266174 | Amarantus BioScience Holdings, Inc. | user2@example.com | None | 2011-08-31 | 2012-11-30 | 2013-11-30 | - | - | 2025-07-14 |
| Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds | NCT01655407 | Amarantus BioScience Holdings, Inc. | user2@example.com | None | 2016-09-30 | 2020-07-31 | 2021-07-31 | - | - | 2025-07-14 |
| A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients | NCT02439125 | Amarantus BioScience Holdings, Inc. | user2@example.com | None | 2015-05-31 | 2017-12-31 | 2018-12-31 | - | - | 2025-07-14 |